Rheumatoid Arthritis News
| Jul 28, 2010 – SOURCE: Swiss Medical Weekly | |||
 |
|
Swiss Consensus Statement: Recommendations for optimising re-treatment with MabThera(R) (rituximab) in rheumatoid arthritis | |
| Rituximab is an effective treatment of rheumatoid arthritis (RA), which has been approved for the treatment of moderate to severe disease in patients with an inadequate response to anti-TNF therapies. Rituximab differs from other available biological agen | |||
| Jul 28, 2010 – SOURCE: Archivos de Bronconeumologia | |||
|
|
Lung Sarcoidosis Induced by TNF Antagonists in Rheumatoid Arthritis: A Case Presentation and a Literature Review | |
| We report on a 72 year-old woman with long-standing rheumatoid arthritis diagnosed as granulomatosis due to pulmonary sarcoidosis after 49 months of treatment with etanercept. A clinical and radiological improvement was seen after tumor necrosis factor (T | |||
| Jul 27, 2010 – SOURCE: Joint Bone Spine | |||
|
|
Rheumatoid arthritis and periodontal disease | |
| The prevalence of periodontal disease has increased two-fold among patients with rheumatoid arthritis (RA) compared to the general population. This increased prevalence is unrelated to secondary Sjögren's syndrome but instead reflects shared pathogenic m | |||
| Jul 22, 2010 – SOURCE: DGNews | |||
|
|
TopAbstracts in Rheumatoid Arthritis 07/22/2010 | |
| TopAbstracts - Past 14 days |
|||
| Jul 21, 2010 – SOURCE: Journal of Clinical Pharmacology | |||
|
|
Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis | |
| Golimumab is a human immunoglobulin G1kappa monoclonal antibody that binds with high affinity and specificity to tumor necrosis factor-alpha. The objective of this study was to establish an approach for exposure-response modeling for golimumab in patients | |||
| Jul 20, 2010 – SOURCE: Zeitschrift für Rheumatologie | |||
|
|
Bacterial infections of the rheumatoid foot | |
| BACKGROUND: A high incidence of infections has been reported in rheumatoid arthritis (RA) patients, either due to intrinsic factors or as a side effect of immunosuppressive agents used for treatment. The present article provides an overview of incidence a | |||
| Jul 20, 2010 – SOURCE: Joint Bone Spine | |||
|
|
Chronic eosinophilic pneumonia (Carrington's disease) and rheumatoid arthritis | |
| We describe the case of a 60-year-old woman with chronic eosinophilic pneumonia (Carrington's disease) who developed symmetric rheumatoid factor-negative polyarthritis suggestive of rheumatoid arthritis. Although these two diseases are well documented as | |||
| Jul 19, 2010 – SOURCE: Rheumatology | |||
|
|
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review | |
| Objective. Serological markers are thought to be useful in predicting which patients with early inflammatory arthritis (EIA) will progress to RA. The objective of this study is to determine the per cent RF and anti-CCP seroconversion in EIA patients at 1- | |||
| Jul 16, 2010 – SOURCE: Joint Bone Spine | |||
|
|
Outcome and safety of TNFalpha antagonist therapy in 475 consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials | |
| OBJECTIVE: To investigate the effectiveness and safety of TNFalpha antagonists in patients with rheumatoid arthritis (RA) or spondyloarthropathies (SpA) treated by a single physician, according to the presence of the inclusion and non-inclusion criteria u | |||
| Jul 16, 2010 – SOURCE: Seminars in Arthritis and Rheumatism | |||
|
|
A Randomized Trial of Three Psychosocial Treatments for the Symptoms of Rheumatoid Arthritis | |
| OBJECTIVE: To assess and compare the benefits of 3 psychosocial treatments for rheumatoid arthritis (RA). METHODS: RA patients were randomized to cognitive-behavior therapy (CBT), relaxation response training (RR), or arthritis education (AE). All treatme | |||
